Today: November 13, 2024
Today: November 13, 2024

Latest From Sriparna Roy

Business|Finance|Health

Cigna says it is not pursuing deal with rival Humana, shares rise

Cigna Group said on Monday it is not pursuing a combination with rival health insurer Humana, days after Donald Trump's reelection as U.S. president raised

Cigna says it is not pursuing deal with rival Humana, shares rise
Economy|Health|US

US hospitals see post pandemic catch-up behind insurer healthcare costs

Americans are catching up on healthcare missed during the COVID-19 pandemic, a trend driven by heart procedures and outpatient orthopedic surgeries that

US hospitals see post pandemic catch-up behind insurer healthcare costs
Health|News|Science|US

US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients

Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of low

US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Health|News|Science|US

US FDA staff raises concerns over data from MDMA-based PTSD therapy

The U.S. health regulator's staff said on Friday data on the psychedelic drug MDMA for post-traumatic stress disorder was difficult to interpret, and raised

US FDA staff raises concerns over data from MDMA-based PTSD therapy
US

US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump

The U.S.

US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump
US

US FDA panel votes against first MDMA-based PTSD treatment

Advisers to the U.S.

US FDA panel votes against first MDMA-based PTSD treatment
Health

Added health benefits of Wegovy, Zepbound could attract more men, doctors say

Evidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep apnea and address other health

Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Business|Finance|Health|US

Drugmakers kick off industry conference with two cancer deals

Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, igniting

Drugmakers kick off industry conference with two cancer deals
Business|News|Science

Musk's Neuralink says tiny wires of brain chip in first patient now stable

The tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable", a

Musk's Neuralink says tiny wires of brain chip in first patient now stable
Business|Finance|Technology|US

UnitedHealth expects bigger hit to profit from tech unit hack

UnitedHealth forecast on Tuesday a bigger hit to annual earnings from a February hack at its tech unit, but maintained its full-year profit

UnitedHealth expects bigger hit to profit from tech unit hack
Business|Finance|Health

Health insurer Elevance cautious on Medicaid business this year

Elevance Health signaled medical costs would remain high this year as the insurer expects more claims in the second half from members enrolled in its

Health insurer Elevance cautious on Medicaid business this year
Business|Finance|Health

Health insurer Centene confident about improving costs next year

Centene Corp said on Friday it expects medical costs to improve next year as states catch up with reassessment of enrollments for its Medicaid plans that

Health insurer Centene confident about improving costs next year
Business|Finance|Health

CVS Health expects medical costs to remain high through the year

CVS Health said on Wednesday that high demand for medical care among older adults hit second-quarter results, a trend that continued into July,

CVS Health expects medical costs to remain high through the year
News|US

US FDA declines to approve first MDMA-based PTSD treatment

The U.S.

Business|Health|US

Lilly demands doctors stop selling copycat weight-loss drugs

Eli Lilly has sent cease-and-desist letters to U.S. healthcare providers in recent days to stop the promotion of the compounded versions of its drugs

Business|Health

UnitedHealth tech unit's rivals say new, post-hack customers are staying

Smaller rivals to UnitedHealth's tech unit Change Healthcare say they are signing longer-term contracts with hospitals and other customers who had temporarily

UnitedHealth tech unit's rivals say new, post-hack customers are staying
Health|News|World

Dozens of health workers killed in Lebanon over past day, WHO says

At least 28 on-duty medics have been killed in the past 24 hours in Lebanon, where Israel has launched airstrikes and sent troops to fight Hezbollah

Dozens of health workers killed in Lebanon over past day, WHO says
Business|Health|US

CVS names Joyner as CEO under investor pressure, withdraws profit forecast

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including

CVS names Joyner as CEO under investor pressure, withdraws profit forecast
Business|Finance|Health|Stock Markets

Health insurer Centene eases investor fears with better-than-expected profit

Centene beat Wall Street estimates for third-quarter earnings on strength in its commercial health insurance plans and maintained its annual profit forecast,

Health insurer Centene eases investor fears with better-than-expected profit
Business|Economy|Finance|Health

CVS names former UnitedHealth exec to run Aetna, shares jump

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising medical costs in the third quarter

CVS names former UnitedHealth exec to run Aetna, shares jump
Business|Finance|Health|Stock Markets

Cigna forecasts 2025 profit growth of at least 10% after quarterly beat

Cigna projected 2025 profit growth of at least 10% on Thursday, after posting quarterly results that beat Wall Street expectations, driven by strong demand for its specialty

Cigna forecasts 2025 profit growth of at least 10% after quarterly beat
Business|Finance|Stock Markets|US

Humana tops estimates on strength in Medicare and primary care

Humana beat Wall Street estimates for third-quarter profit on Wednesday as it added more members than expected in its government-backed Medicare Advantage

Humana tops estimates on strength in Medicare and primary care
Business|Finance|Health|Technology

Boston Scientific to buy Silk Road Medical in $1.16 billion deal

Boston Scientific will buy Silk Road Medical in a $1.16 billion deal, the company said on Tuesday, adding medical devices used for stroke prevention.

US

US FDA approves Elanco's skin disease treatment for dogs

The U.S.

US FDA approves Elanco's skin disease treatment for dogs
Business|Finance|Health

Insurer Humana flags higher medical care use, shares slide

Humana said on Wednesday that demand for medical care was higher than it had anticipated in the second quarter, dampening investor hopes that elevated costs in the Medicare

Insurer Humana flags higher medical care use, shares slide

Follow